The candidate immunotherapeutical target, the receptor for hyaluronic acid-mediated motility, is associated with proliferation and shows prognostic value in B-cell chronic lymphocytic leukemia

Erstveröffentlichung
2009
Metadata only
Search for full text

Wissenschaftlicher Artikel

Autoren
Giannopoulos, K.
Mertens, D.
Buehler, A.
Barth, T. F. E.
Idler, I.
et al.
Institutionen
UKU. Klinik für Innere Medizin III
UKU. Institut für Pathologie
Erschienen in
Leukemia ; 23 (2009), 3. - S. 519-527. - ISSN 0887-6924
Link zur Veröffentlichung
https://dx.doi.org/10.1038/leu.2008.338
Förderinformationen
Polish Scientific Committee [N402 034 31/1138, N402 107 32/3496]
Deutsche Krebshilfe [106142, 108060]
Schlagwörter
B-cell chronic lymphocytic leukemia (B-CLL); tumor-associated antigens (TAAs); cytotoxic T lymphocytes (CTL); receptor for hyaluronic acid mediated motility (RHAMM/CD168); tumor-associated antigens; acute myeloid-leukemia; multiple-myeloma; mutation status; soluble cd44; high-risk; expression; rhamm; disease; protein
DDC-Sachgruppe
DDC 610 / Medicine & health
Metadata
Zur Langanzeige